Brucellosis in low-income and middle-income countries

MP Rubach, JEB Halliday, S Cleaveland… - Current opinion in …, 2013 - journals.lww.com
Brucellosis causes substantial morbidity in human and animal populations. While
improvements in diagnostic options for resource-limited settings and stronger evidence for …

The current therapeutical strategies in human brucellosis

M Bosilkovski, F Keramat, J Arapović - Infection, 2021 - Springer
Prompt and adequate treatment of human brucellosis continues to be the most important
strategy in its management, as eradication of animal brucellosis is not possible so far, and …

Antibiotics for treating human brucellosis

R Yousefi‐Nooraie, S Mortaz‐Hejri… - Cochrane Database …, 2012 - cochranelibrary.com
Background Brucellosis is the most common zoonotic infection in the world. Several
antibiotics, separately or in combination, have been tried for treatment of human brucellosis …

[HTML][HTML] Treatment of brucellosis: a systematic review of studies in recent twenty years

SM Alavi, L Alavi - Caspian journal of internal medicine, 2013 - ncbi.nlm.nih.gov
Background: The treatment of human brucellosis is controversial. The purpose of this study
was to search published clinical trial papers to provide a simple and effective treatment in …

Efficacy of Mass Antimicrobial Treatment of Foals with Subclinical Pulmonary Abscesses Associated with Rhodococcus equi

M Venner, K Astheimer, M Lämmer… - Journal of veterinary …, 2013 - Wiley Online Library
Background Mass antimicrobial treatment of foals with small subclinical ultrasonographic
pulmonary lesions is empirical practice on many farms with endemic disease caused by …

[HTML][HTML] Use of the quantum dot-labeled solid lipid nanoparticles for delivery of streptomycin and hydroxychloroquine: A new therapeutic approach for treatment of …

Z Karimitabar, Z Chegini, L Shokoohizadeh… - Biomedicine & …, 2023 - Elsevier
Brucellosis is considered one of the most important infectious diseases affecting any tissue
and organ in the human body. Due to the intracellular pathogenesis of Brucella species, the …

Co-delivery of doxycycline and hydroxychloroquine using CdTe-labeled solid lipid nanoparticles for treatment of acute and chronic brucellosis

SM Hosseini, A Farmany, MY Alikhani, M Taheri… - Frontiers in …, 2022 - frontiersin.org
Brucellosis is a systemic disease in both acute and chronic forms which can affect any organ
or tissue in the body. One of the biggest issues in treating this disease is its relapse. In this …

Combination of doxycycline, streptomycin and hydroxychloroquine for short-course treatment of brucellosis: a single-blind randomized clinical trial

MM Majzoobi, SH Hashmi, K Emami, AR Soltanian - Infection, 2022 - Springer
Purpose Previous studies have shown the effect of hydroxychloroquine in the treatment and
prevention of recurrence of brucellosis. The aim of this study was to compare the effect of 4 …

Clinical and diagnostic aspects of brucellosis and antimicrobial susceptibility of Brucella isolates in Hamedan, Iran

FT Asadi, SH Hashemi, MY Alikhani… - Japanese journal of …, 2017 - jstage.jst.go.jp
Current drug regimens for brucellosis are associated with relatively high rates of therapeutic
failure or relapse. Reduced antimicrobial susceptibility of Brucella spp. has been proposed …

The many faces of brucellosis: diagnostic and management approach

C Challita, SS Kanj - Current Opinion in Infectious Diseases, 2024 - journals.lww.com
The findings underscore the necessity for clinicians to adopt a comprehensive approach to
diagnosing and managing brucellosis. Integrating advanced diagnostic tools with tailored …